Apart from early genetic diagnosis, combined lifestyle and dietary interventions, a glucagon-like peptide 1 (GLP-1) analog, liraglutide, was recently shown to be effective as anti-obesity treatment for one case with typical and one case with distal 16p11.2 BP2-BP3 deletion [32]. Here, IGFBP2 is linked to Obesity.